Synthetic epidermal growth factor receptor inhibitor conjugated with nobel metal nanoparticles as a potential drug for targeted therapy against pancreatic cancer
2021/41/N/NZ7/04480
Keywords
Descriptors
- NZ5_007: Leczenie chorób człowieka
- NZ7_014: Farmacja, farmakoterapia, farmakologia
- ST5_010: Materiały /nanomateriały funkcjonalne, nanocząstki
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny
Voivodeship: pomorskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 3
Call
PRELUDIUM 20 – announced on 2021-03-15
- Amount awarded
- 209 993 PLN
- Project start date
- 2022-02-04
- Project end date
- 2027-02-03
- Project duration
- 60 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
Graphene Oxide Nanoparticles and Organoids: A Prospective Advanced Model for Pancreatic Cancer Research
- Authors:
- Shaoshan Mai, Iwona Inkielewicz-Stepniak
- Academic press:
- International Journal of Molecular Sciences (year: 2023, volume: 25(2), pages: 1066), Publisher: MDPI
- Status:
- Published
- DOI:
- 10.3390/ijms25021066 – link to the publication